Document is current

Any future updates will be listed below

Nivolumab plus palliative Chemotherapie

Crossref DOI link: https://doi.org/10.1007/s15004-022-8941-6

Published Online: 2022-02-02

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark